Cargando…
Treating COVID-19 with Chloroquine
Autores principales: | Huang, Mingxing, Tang, Tiantian, Pang, Pengfei, Li, Man, Ma, Ruolan, Lu, Jiahui, Shu, Jingxian, You, Yingying, Chen, Binghui, Liang, Jiabi, Hong, Zhongsi, Chen, Huili, Kong, Ling, Qin, Dajiang, Pei, Duanqing, Xia, Jinyu, Jiang, Shanping, Shan, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232130/ https://www.ncbi.nlm.nih.gov/pubmed/32236562 http://dx.doi.org/10.1093/jmcb/mjaa014 |
Ejemplares similares
-
Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19
por: Huang, Mingxing, et al.
Publicado: (2020) -
Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study
por: Liu, Xi, et al.
Publicado: (2020) -
RAREMETAL: fast and powerful meta-analysis for rare variants
por: Feng, Shuang, et al.
Publicado: (2014) -
RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data
por: Zhan, Xiaowei, et al.
Publicado: (2016) -
HiCube: interactive visualization of multiscale and multimodal Hi-C and 3D genome data
por: Ye, Tiantian, et al.
Publicado: (2023)